GANXGain Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 15825
Ticker: GANX
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2021-03-18
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: GANX

Detail

Enriched 2026-08-14 20:47

Market cap: $90,426,560.56
Shares outstanding (class): 42,654,038
Shares outstanding (weighted): 42,654,038
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 21
Location: BETHESDA, MD
Homepage: https://www.gaintherapeutics.com
Description: Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

Market cap and share counts drift.

Funds holding this security

6 funds · 6 positions · $1.02M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$775.8K	0.00%	399,886 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$185.2K	0.02%	95,486 NS	FIGI
Ultra-Small Company Market Fund Bridgeway Funds, Inc.	—	$58.2K	0.05%	30,004 NS	FIGI
1290 VT Micro Cap Portfolio EQ Advisors Trust	—	$12.6K	0.01%	6,513 NS	FIGI
Total Stock Market Index Trust John Hancock Variable Insurance Trust	—	$1.4K	0.00%	733 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	-$9.5K	-0.00%	-4,900 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERGANX
FIGI_COMPOSITEBBG00W7D7CJ9
FIGI_SHARE_CLASSBBG00W7D7CK7
CIK0001819411
ISINUS36269B1052
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: The company is a pharmaceutical preparation firm per SIC code 2834, so it maps to EQUITY | HEALTHCARE | PHARMACEUTICALS.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.